Market Overview

InfoBionic Signs BIOTRONIK as Exclusive U.S. Distributor for MoMe® Kardia

Share:

InfoBionic, a digital health company focused on creating next-generation
solutions for ambulatory, cardiac arrhythmia monitoring, today announced
an exclusive, strategic
agreement
with medical device manufacturer BIOTRONIK for U.S.
distribution of InfoBionic's proprietary MoMe® Kardia system, effective
immediately.

"BIOTRONIK is a trusted technology provider throughout the healthcare
industry and we believe that our new partnership will drive increased
nationwide acceptance and sales of the MoMe® Kardia system," said Stuart
Long
, InfoBionic Chief Executive Officer. "With expanded access to
MoMe® Kardia, patient care and treatment can be enhanced at reduced
expense because our innovative system provides physicians and practices
with high-quality cardiac data to speed diagnosis and decision making."

MoMe®
Kardia
, which has been granted 501(k) clearance from the U.S. Food
and Drug Administration since 2015, is a Software as a Service (SaaS)
platform for remote cardiac monitoring that replicates in-hospital
monitoring. The system generates and delivers cardiac data direct to
physicians for 24/7, on-demand review via a HIPAA-compliant portal. With
expanded control of monitoring reports – including access to
beat-to-beat data to verify events – physicians can significantly reduce
time to diagnosis and intervention. The innovative MoMe® Kardia model
also positively impacts practice economics by giving physicians full
ownership of monitoring services, Long said.

Cardiac specialist Matthew B. Hillis, MD, FACC, FHRS of Marple Medical
Associates in Broomall, Pennsylvania has discovered the benefits to his
practice from using the MoMe® Kardia system. "The workflow has been more
efficient for us from both the staff and physician perspective," Dr.
Hillis said. "Customizable alerts, utilization tracking/inventory
management, improved patient comfort, and compliance have been
beneficial. The quality of ECG tracings is high, and we have found the
business model to be useful as well."

About InfoBionic

InfoBionic is a digital health company focused on creating next
generation patient monitoring solutions for chronic disease management
with an initial market focus on cardiac arrhythmias. InfoBionic's lead
product, MoMe® Kardia, is the only remote cardiac arrhythmia detection
and monitoring system that replicates in-hospital telemetry data, right
in the office, by giving physicians 24/7 on-demand access to full
disclosure Holter, Event, and MCT data via a HIPAA-compliant portal app.
For more information, visit www.infobionic.com.

About BIOTRONIK

BIOTRONIK is a leading medical device company headquartered in Berlin,
Germany, and represented in more than 100 countries. Our products save
and improve the lives of millions of patients with heart and blood
vessel diseases every year. Since developing the first German pacemaker
in 1963, BIOTRONIK continues to innovate cardiovascular and endovascular
services and solutions. BIOTRONIK has U.S. offices in Lake Oswego,
Oregon and New York City. For more information, visit https://www.biotronik.com/en-us/about-us.

View Comments and Join the Discussion!